Page 87 - Relevant Persons News Today

DGAP-Ad-hoc: Lakestar SPAC I SE / Key word(s): Capital Increase Lakestar SPAC I SE launches bookbuilding for up to EUR 275 million private placement and listing on Frankfurt Stock Exchange and

VALLOUREC: Vallourec reports fourth quarter and full year 2020 results Boulogne-Billancourt (France), February 17 th 2021 - Vallourec, a world leader in premium tubular solutions, today announces its results for the fourth quarter and full year of 2020. The consolidated financial information was presented by Vallourecs Management Board to its Supervisory Board on February 16 t h 2021. €3,242 million revenue, down 22% year-on-year (-15% at constant exchange rates) €258 million EBITDA versu...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Vallourec reports fourth quarter and full year 2020 results VALLOURECFebruary 17, 2021 GMT Vallourec reports fourth quarter and full year 2020 results Boulogne-Billancourt (France), February 17th 2021 – Vallourec, a world leader in premium tubular solutions, today announces its results for the fourth quarter and full year of 2020. The consolidated financial information was presented by Vallourec’s...

th 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH DISTRIBUTION WOULD BE UNLAWFUL.     This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities and the offer of Nacon shares in the concurrent accelerated bookbuilding and of the offer of the ...

Tremendous success for MedinCells €30 million capital increase for qualified investors Strong support from French and international leading shareholders and investors Regulatory News: MedinCell (Paris:MEDCL) (FR0004065605 MEDCL), a clinical stage pharmaceutical company developing a portfolio of long-acting injectable products in various therapeutic areas (the " Company"), is today announcing the successful completion of its €29.8 million capital increase via a placement with French and int...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS DIRECTED ONLY AT PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING, HOLDING, MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE: (A) IF IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (THE "EEA"), QUALIFIED INVESTORS WITHIN T...

MedinCell Announces a Capital Increase of a c.€30 Million Portefeuille au 31 janvier 2021 (Graphic: Business Wire) This press release is not intended for publication or distribution in the United States, Canada, Japan or Australia. MedinCell (FR0004065605 MEDCL) (Paris:MEDCL), a clinical stage pharmaceutical company developing a portfolio of long-acting injectable products in various therapeutic areas (the " Company"), announces today a capital increase of €c.30 million through an offering ...

David (Dave) Pell (Head of Sales & Marketing, aged 58). Dave, who joined the Company in January 2020, has over 30 years experience working in key sales and commercial roles in technology-based businesses. He has run a number of global sales organisations for the largest global IT and technology companies, commercial operations for BT Global Services, and has headed advanced technology divisions at QinetiQ, where he led the focus on technology transition and commercialisation, with a...

IMPORTANT INFORMATION FOR INVITED PLACEES ONLY MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING (AS DEFINED BELOW).  THIS ANNOUNCEMENT AND THE TERMS AND CONDITIONS SET OUT IN THIS APPENDIX ARE FOR INFORMATION PURPOSES ONLY AND ARE DIRECTED ONLY AT: (A) IF IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(E) OF THE PROSPECTUS REGULATION ("QUALIFIED INVESTORS"), (B) IF IN THE UNITED KINGDOM, QUALIFIE...